AU5218500A - Stable, radioactively marked nanoparticles, method for the production and utilization thereof - Google Patents

Stable, radioactively marked nanoparticles, method for the production and utilization thereof

Info

Publication number
AU5218500A
AU5218500A AU52185/00A AU5218500A AU5218500A AU 5218500 A AU5218500 A AU 5218500A AU 52185/00 A AU52185/00 A AU 52185/00A AU 5218500 A AU5218500 A AU 5218500A AU 5218500 A AU5218500 A AU 5218500A
Authority
AU
Australia
Prior art keywords
utilization
stable
production
radioactively marked
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU52185/00A
Inventor
Peter Boderke
Jennifer Filbey
Matthias Ortmuller
Jochen Wermuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Research and Technologies GmbH and Co KG
Original Assignee
Aventis Research and Technologies GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999128496 external-priority patent/DE19928496A1/en
Priority claimed from DE1999133346 external-priority patent/DE19933346A1/en
Application filed by Aventis Research and Technologies GmbH and Co KG filed Critical Aventis Research and Technologies GmbH and Co KG
Publication of AU5218500A publication Critical patent/AU5218500A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21K—TECHNIQUES FOR HANDLING PARTICLES OR IONISING RADIATION NOT OTHERWISE PROVIDED FOR; IRRADIATION DEVICES; GAMMA RAY OR X-RAY MICROSCOPES
    • G21K5/00—Irradiation devices
AU52185/00A 1999-06-22 2000-05-31 Stable, radioactively marked nanoparticles, method for the production and utilization thereof Withdrawn AU5218500A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE1999128496 DE19928496A1 (en) 1999-06-22 1999-06-22 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes
DE19928496 1999-06-22
DE1999133346 DE19933346A1 (en) 1999-07-16 1999-07-16 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes
DE19933346 1999-07-16
PCT/EP2000/004973 WO2000078362A2 (en) 1999-06-22 2000-05-31 Stable, radioactively marked nanoparticles, method for the production and utilization thereof

Publications (1)

Publication Number Publication Date
AU5218500A true AU5218500A (en) 2001-01-09

Family

ID=26053887

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52185/00A Withdrawn AU5218500A (en) 1999-06-22 2000-05-31 Stable, radioactively marked nanoparticles, method for the production and utilization thereof

Country Status (2)

Country Link
AU (1) AU5218500A (en)
WO (1) WO2000078362A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004102196A1 (en) * 2003-04-30 2004-11-25 Chengdu Kuachang Medical Industrial Limited Apparatus including nanostructures used for separation or analysis, and the preparation and application thereof
CN115282298B (en) * 2022-07-21 2023-10-20 苏州知益微球科技有限公司 Preparation method and application of monodisperse yttrium-90 polymer microspheres

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115540A (en) * 1976-06-16 1978-09-19 The University Of Kentucky Research Foundation Radiodiagnostic agent
WO1990003803A1 (en) * 1988-10-14 1990-04-19 Mallinckrodt, Inc. Radiolabelled particulate composition
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
CA2167920A1 (en) * 1993-07-23 1995-02-02 Abraham J. Domb Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US7025991B2 (en) * 1997-06-13 2006-04-11 Nanodel Technologies Gmbh Drug targeting system, method of its preparation and its use
AU3532197A (en) * 1997-07-24 1999-02-16 Australian National University, The Method for detection of fibrin clots
AU1064800A (en) * 1998-11-12 2000-06-05 Nycomed Amersham Plc Products and methods

Also Published As

Publication number Publication date
WO2000078362A2 (en) 2000-12-28
WO2000078362A3 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU5469701A (en) Surface, method for the production thereof and an object provided with said surface
AU1271201A (en) Azepinoindole derivatives, the production and use thereof
AU2002310741A1 (en) Superabsorber, method for the production and use thereof
AU2325900A (en) Exposure device, exposure method, and device manufacturing method
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2001276295A1 (en) Electric component, method for the production thereof, and its use
AU3031899A (en) Nanoparticles, method for producing nanoparticles and use of the same
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HK1056168A1 (en) Imidazole derivatives, production method thereof and use thereof
AU1703301A (en) Block copolymers and method for the production and utilization thereof
AU2351001A (en) Stent and method for the production thereof
AU4600099A (en) Immuno-adsorption matrix, a method for the production thereof, and the utilization thereof
PL351616A1 (en) Polyolefin compositions, method for the production and use thereof
AU4292400A (en) Method for producing barium sulfate, barium sulfate and the utilization thereof
AU5208200A (en) Screwed connection, fastener for said connection and method for the production thereof
AU2298200A (en) Stabilized filler, its production and use
AU2001289695A1 (en) Impregnate, method for the production and use thereof
AU5057600A (en) Component and method for the production thereof
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
AU3359501A (en) Fertilizer, ion exchanger and method for the production thereof
HK1034706A1 (en) Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
AU2002231666A1 (en) Photosensitive microcapsules, method for the production thereof, and their use in adhesives
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU7563800A (en) Marsh-mallow and the marsh-mallow production technique

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant